PSNL — Personalis Inc. stock price and chart

PSNL

$15.94+0.38%

as of close, Oct 20, 2026

☾ AH $15.94 +0.38%

Personalis Inc.Stock · HealthcareRussell 2000 · 0.03% of IWMUS Stock Market · 0.001% of VTIRussell 3000 · 0.001% of IWV

PeersRVTYGHSPYQQQNVDAAAPL

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

Available history since Jun 25, 2019

VolumeEEEEEEEEEEEE

20192021202320242026

5.010.015.020.025.030.035.040.045.050.0020.0M$15.94

2026-10-20

Price$15.94

MA20$15.18

MA50$10.99

Vol10.7M

What would $1,000 invested in PSNL be worth today? →

PSNL returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $15.94
YTD price return: +100.25%
YTD total return: +100.25%
Next earnings: Nov 3, 2026
Market cap: 1.7B2019-09 458.4M2026-10 1.7B+271.4% over the window
Enterprise value: 1.5B
Shares outstanding: 106.8M2018-12 3.1M2026-06 106.8M+3361.6% over the window
52W low: $4.96
52W high: $18.89
From 52W high: -15.62%
From 52W low: +221.70%
52W range: 79%

Volume

Rel volume: 0.91×
30D volume: 2.3M
30D $ vol: 37.5M

Fundamentals

Sales (ttm): 69.7M2017-12 9.4M2026-06 69.7M+641.7% over the window
Sales/share: $0.652018-12 $12.242026-06 $0.65-94.7% over the window
EPS (ttm): -$1.102020-12 -$1.202026-06 -$1.10-8.5% over the window
FCF (ttm): -101M2017-12 -4.9M2026-06 -101M+1974.3% over the window
FCF/share: -$0.952018-12 -$0.742026-06 -$0.95+27.9% over the window
Book value/share: $2.202018-06 -$32.672026-06 $2.20-106.7% over the window
Net margin: -153.84%2017-12 -251.2%2026-06 -153.8%-38.8% over the window
ROE: -45.58%2019-06 -16.0%2026-06 -45.6%+184.4% over the window
ROA: -34.34%2018-12 -47.7%2026-06 -34.3%-28.0% over the window
Current ratio: 5.282018-12 0.512026-06 5.28+933.9% over the window

Growth (CAGR, ttm) · 10Y

Sales: -13.27%2025-06-30 → 2026-06-3080.3M → 69.7M (-13.3% total)+1.24%2023-06-30 → 2026-06-3067.1M → 69.7M (+3.8% total)-3.33%2021-06-30 → 2026-06-3082.5M → 69.7M (-15.6% total)n/a
Shares: +20.45%2025-06-30 → 2026-06-3088.7M → 106.8M (+20.4% total)+30.08%2023-06-30 → 2026-06-3048.5M → 106.8M (+120.1% total)+19.19%2021-06-30 → 2026-06-3044.4M → 106.8M (+140.5% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: -27.99%2025-06-30 → 2026-06-30$0.91 → $0.65 (-28.0% total)-22.17%2023-06-30 → 2026-06-30$1.38 → $0.65 (-52.9% total)-18.90%2021-06-30 → 2026-06-30$1.86 → $0.65 (-64.9% total)n/a
Book value/share: +2.32%2025-06-30 → 2026-06-30$2.15 → $2.20 (+2.3% total)-15.34%2023-06-30 → 2026-06-30$3.63 → $2.20 (-39.3% total)-22.00%2021-06-30 → 2026-06-30$7.63 → $2.20 (-71.1% total)n/a
Price: +57.56%2025-10-20 → 2026-10-20$10.12 → $15.94 (+57.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+156.13%2023-10-20 → 2026-10-20$0.95 → $15.94 (+1581.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-4.05%2021-10-20 → 2026-10-20$19.60 → $15.94 (-18.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a
Total return: +57.56%2025-10-20 → 2026-10-20$10.12 → $15.94 (+57.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+156.13%2023-10-20 → 2026-10-20$0.95 → $15.94 (+1581.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.05%2021-10-20 → 2026-10-20$19.60 → $15.94 (-18.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -14.5×2019-09 -20.842026-10 -15.88-23.8% over the window
Fwd P/E: -16.9×
P/S (ttm)Market cap ÷ TTM revenue.: 24.4×2019-09 7.612026-10 24.44+221.0% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 7.2×2019-09 4.112026-10 7.24+75.9% over the window
EV/Sales (ttm): 21.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -5.93%2019-06 -2.9%2026-06 -7.1%+139.9% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 106.8M ÷ 88.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -20.45%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-20.45%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($581.7M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -20.45%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-134.5M) ÷ today's market cap ($1.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: -7.90%2019-06 0.0%2026-06 -9.4%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-134.5M + TTM dividends $0) ÷ today's market cap ($1.7B). Same caveat as the cash buyback yield.: -7.90%2019-06 0.0%2026-06 -9.4%

Vs own 10Y history

P/S: 98th
P/B: 94th

Bar = where today’s multiple sits in PSNL’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+0.38%

+0.57%

-2.80%

+19.49%

YTD

+100.25%

+57.51%

-18.67%

Financial statements

Open full PSNL financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

PSNL — Personalis Inc. price, chart and key statistics